1-(6-ethoxy-5-(3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo(4,3-d)pyrimidin-5-yl)-3-pyridyl sulphonyl)-4-ethylpiperazine,
1-(6-ethoxy-5-(3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo(4,3-d)pyrimidin-5-yl)-3-pyridyl sulphonyl)-4-ethylpiperazine benzenesulphonate,
UK 369,003,
UK 369003,
UK-369,003,
UK-369003,
UK369,003,
UK369003,
GISADENAFIL BESYLATE,
334827-98-4,
UNII-T4S08274OY,
UK 369003,
Gisadenafil besylate salt,
Gisadenafil besylate [USAN],
T4S08274OY,
UK 369003-26,
Gisadenafil besylate (USAN),
5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4,3-d]pyrimidin-7-one Benzenesulfonate,
5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4,3-d]pyrimidin-7-one benzenesulfonate besylate salt,
SCHEMBL3583099,
CHEMBL2103843,
DTXSID20187125,
MFCD18384964,
AKOS024458010,
CCG-221539,
Gisadenafil besylate salt, >=98% (HPLC),
B7599,
PF 01224715,
D09622,
UK-369003-26,
UK-369,003-26,
J-019206,
1-[[6-Ethoxy-5-[3-ethyl-4,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridinyl]sulfonyl]-4-ethylpiperazine Monobenzenesulfonate,
5-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)pyridin-3-yl)-3-ethyl-2-(2-methoxyethyl)-2,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one benzenesulfonate,
5-(2-ethoxy-5-(4-ethylpiperazin-1-ylsulfonyl)pyridin-3-yl)-3-ethyl-2-(2-methoxyethyl)-2H-pyrazolo[4,3-d]pyrimidin-7(6H)-one benzenesulfonate,
7H-Pyrazolo(4,3-d)pyrimidin-7-one, 5-(2-ethoxy-5-((4-ethyl-1-piperazinyl)sulfonyl)-3-pyridinyl)-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-, benzenesulfonate (1:1),
benzenesulfonic acid,5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)su,
334826-98-1,